Background-Individuals with tetralogy of Fallot (TOF) now routinely survive to reproductive age and beyond. Reproductive fitness of adults with TOF and recurrence risks to offspring are of increasing interest in the modern era, especially given recent molecular genetic discoveries. Methods and Results-After excluding individuals with known genetic syndromes, 543 unrelated adults with TOF underwent a detailed family history assessment and molecular characterization for rare copy number variations using high-resolution genome-wide microarrays. Men and women with TOF had significantly fewer offspring compared with an age-matched comparison group without congenital heart disease (CHD; P=0.0004). No aspect of rare copy number variation burden was a predictor of decreased reproductive fitness. Corresponding with the advent of modern surgical repairs, reproductive fitness of women began to exceed that of men (P=0.0490). Recurrence risk for CHD in offspring was 4.8%, with no significant differences between men and women with TOF. The risk of severe CHD in offspring (2.3%) far exceeded population expectations (relative risk, 15.6; 95% confidence interval, 7.9-31.0). Most cases of vertical transmission of CHD were not explained by the transmission of a large rare copy number variation. Although conotruncal lesions (31.5%) were the most commonly reported CHD in relatives, the familial spectrum of disease included many anatomically discordant lesions. Conclusions-Men and women with TOF have reduced reproductive fitness. Their offspring are at significantly elevated risk for severe CHD. These results support the importance of genetic counseling for both men and women with complex CHD. Many inherited genetic variants remain to be discovered. (Circ Cardiovasc Genet. 2014;7:102-109.)
W ith an estimated prevalence in live births of 1%, congenital heart disease (CHD) is the most common major congenital malformation in humans. 1 Tetralogy of Fallot (TOF) accounts for ≈4% of all CHD and is the most common of the cyanotic defects. 1, 2 Advances in pediatric surgical management during the past several decades have resulted in a large and growing adult cohort with TOF. 3 With patients surviving to reproductive age and beyond, there is a need for data to (1) comprehend the contemporary evolutionary selective pressure against TOF, and (2) inform genetic and reproductive counseling. 4 There are no previous studies of either reproductive fitness in adults with TOF of unknown cause (ie, excluding 22q11.2 deletions and other established syndromes), or of recurrence rates of CHD in the offspring of these men and women.
Clinical Perspective on p 109
New molecular technologies, including chromosomal microarray analysis to identify rare copy number variations (CNVs), are beginning to shed light on the genetic origins of CHD. [5] [6] [7] [8] [9] [10] [11] Rare CNVs 7 and syndromal (extracardiac) features 7, 12 could influence reproductive fitness and transmission patterns in TOF, as is the case with 22q11.2 deletions and the associated 22q11.2 deletion syndrome (22q11.2DS). [13] [14] [15] [16] [17] [18] Furthermore, an understanding of typical familial segregation patterns and other aspects of family history would help with the interpretation of emerging and novel molecular genetic risk factors (both de novo and inherited) for TOF.
We used a novel approach combining established genetic epidemiological methods with genome-wide CNV data 7 to assess reproductive fitness and familial transmission patterns in a large adult TOF cohort without 22q11.2 deletions. We hypothesized that reproductive fitness would be significantly reduced in this adult TOF cohort when compared with an age-matched comparison group without CHD, and that fitness would be associated with specific genotypic and phenotypic features within the TOF group. We generated contemporary empirical recurrence risk estimates for CHD in offspring and other relatives of individuals with TOF of unknown origin and investigated the extent to which rare CNVs were associated with vertical transmission of CHD and other aspects of family history. Finally, we further delineated the genetically related spectrum of CHD within families with TOF, anticipating both anatomically concordant and anatomically discordant lesions.
Methods

Ethics Statement
Written consent was obtained from all research participants, and the study was approved by the institutional ethics boards of the University Health Network and the Centre for Addiction and Mental Health.
Clinical and Molecular Characterization of Participants
The study population comprised consecutive unrelated adults (>17 years) with TOF seen at the Toronto Congenital Cardiac Center for Adults (TCCCA) and is described in detail elsewhere. 7, 12 Briefly, diagnoses of TOF were confirmed by echocardiogram and cardiac catheterizations, as well as review of lifetime medical records; this sample is representative of adults with TOF with respect to cardiac and functional outcomes. 7, 12 Individuals with known genetic syndromes such as 22q11.2DS and trisomy 21 (Down syndrome) were excluded a priori from this cohort. In total, 575 individuals with TOF were available for study after these initial exclusions. Thirty-two individuals were subsequently excluded either because they were adopted with no knowledge of their family of origin (n=9) or because a detailed family history was otherwise unavailable (n=23). The remaining 543 probands (median age, 32.9 years; interquartile range, 20.9 years; 55.8% men) comprised the sample population: n=428 (78.8%) white, n=39 (7.2%) East/Southeast Asian, n=28 (5.2%) South Asian, n=15 (2.8%) black, and n=33 (6.1%) other/admixed.
All participants underwent a structured clinical assessment for extracardiac features blind to genotype 12, 19 and were classified as syndromic if they met at least 2 of 3 criteria: dysmorphic facial features, hypernasal voice, and history of learning difficulties. 7, 19 Standard karyotype analysis and fluorescence hybridization with a standard probe from the 22q11.2 region, 19 and high-resolution Affymetrix Genome-Wide Human SNP Array 6.0 CNV analysis and adjudication, 7 was performed for 64 (88%) of 73 syndromic and 355 (76%) of 470 nonsyndromic patients; none had a 22q11.2 deletion.
Family History Collection
All study participants were assessed for a family history of CHD, and pedigrees were constructed for each family using Progeny software (Version 8.2.05; Delray Beach, FL), with the individual with TOF followed at the TCCCA designated as the proband. First-degree relatives of the proband included parents, siblings, and offspring. Second-degree relatives included grandparents, aunts, uncles, nieces, nephews, and half-siblings. Third-degree relatives were predominantly first cousins, and all relatives greater than third degree were termed distant relatives. Pedigrees that included second-degree and third-degree relatives were drawn for 478 (88%) and 319 (59%) of the probands, respectively. Families where only the proband had CHD were designated as simplex families, and those where ≥1 family members within 3 degrees of relation to the proband had CHD were designated as multiplex families. Of the 4 probands who were members of a monozygotic twin pair, 3 had a twin affected by CHD but no other family history of CHD; these families were classified as simplex families.
Each relative with CHD was assigned 1 primary cardiac diagnosis by history. We conducted follow-up assessments, including interviews and review of available medical records, to verify cardiac diagnoses given at the initial screening. This included obtaining a clinical history of the presence of cyanosis, failure to thrive, any cardiac surgery or other follow-up, and age at death of relatives with CHD. CHD in relatives was designated unspecified when a satisfactory history consistent with a congenital cardiac lesion and intracardiac surgery in infancy or early childhood was obtained, but a specific cardiac diagnosis was unavailable. As a conservative measure, neither a history of an unspecified heart murmur nor any later onset cardiac conditions were recorded as CHD.
Analyses
Reproductive fitness is an essential concept in evolutionary biology and genetics that involves the ability of organisms, including human males and females, to survive and reproduce. 20 The relative reproductive fitness associated with TOF was assessed using 2 standard proxies: the mean number of liveborn offspring per proband and the proportion of probands who were childless. 13, 21 The comparison group consisted of Canadian adults with neither CHD nor 22q11.2 deletions, used in a previous study of reproductive fitness and representative of men and women in the general population. 13 The TOF group and the comparison group were well matched with respect to age and birth cohort. Relative reproductive fitness was defined as the ratio of mean numbers of liveborn offspring in TOF compared with the unaffected controls. 13 Between-group comparisons were performed using (1) a multivariable Poisson regression model for mean number of liveborn offspring, and (2) a multivariable logistic regression model for childlessness, both with group (TOF versus comparison), age at ascertainment, and sex as independent variables. Similar multivariable models were constructed for 3 within-TOF analyses, involving (1) all probands, (2) only those born before 1969, and (3) only those born in 1969 or later, who were more likely to have undergone a complete surgical repair as a neonate or in early childhood. 22 Across all analyses, substitution of age at ascertainment for year of birth did not change the results.
Recurrence risks for specific relative categories were calculated as the proportion of all known relatives in this category who had CHD. χ 2 or Fisher exact tests and odds ratios with 95% confidence intervals (CIs) were used to compare categorical variables, and standard nonparametric Mann-Whitney U tests were used to compare continuous variables. For ease of comparison to Canadian population figures, we defined severe CHD as per Marelli et al. 3 This definition included conotruncal and other rarer lesions such as hypoplastic left heart. 3 We also included relatives with unspecified CHD and nonaccidental death before 5 years of age in this category. We compared the offspring recurrence risk for severe CHD in our sample to the population prevalence of severe CHD in children <18 years of age in this large independent Canadian cohort (0.15%). 3 Recurrence risks for all first-to third-degree relatives were compared with general population prevalences of any CHD (0.58%) and severe CHD (0.061%) that were derived from combined numbers for adults and children. 3 The results of these comparisons were expressed as relative risks (RRs) with 95% CIs. 23 All statistical analyses were performed using SAS software (version 9.3; SAS Institute, Cary, NC). A 2-tailed P<0.05 was considered statistically significant.
Results
Reproductive Fitness
Basic demographic and clinical features of the 543 unrelated probands with TOF are presented in Tables 1 and 2 . The mean number of offspring was significantly lower (Z=3.56; P=0.0004), and the proportion of childless was significantly greater (χ 2 =5.97; df=1; P=0.0146; odds ratio, 1.59; 95% CI, 1.10-2.30) in this TOF group than in the age-matched comparison group 13 (Table 3 ). The relative fitness of the TOF group was 0.70. Within the entire TOF cohort, syndromic status was a predictor of childlessness (χ 2 =9.79; df=1; P=0.0018; odds ratio, 3.12; 95% CI, 1.53-6.37), and there was a trend toward a lower mean number of offspring in syndromic individuals (Z=5.80; P=0.0507). Later year of birth (Z=11.73; P<0.0001; χ 2 =90.65; df=1; P<0.0001), but not sex (Z=1.09; P=0.2772; χ 2 =1.62; df=1; P=0.2036), was a significant predictor of a lower mean number of offspring and childlessness, respectively. However, in the subgroup of probands born in 1969 or later, female sex was a significant positive predictor of the mean number of offspring (Z=1.97; P=0.0490) and a significant negative predictor of childlessness (χ 2 =6.03; df=1; P=0.0141; odds ratio, 0.47; 95% CI, 0.26-0.86). For those born before 1969, there was a nonsignificant trend toward higher reproductive fitness in men compared with that in women (data not shown). Across various exploratory models, no form of rare CNV burden (genic or nongenic CNVs, exonic or nonexonic CNVs, gain or loss CNVs, large or all size CNVs, and rare 7 CNVs) was found to be a significant predictor of reproductive fitness (data not shown).
Recurrence Risks for CHD
Eighty-seven (16.0%) of the 543 unrelated probands with TOF were from multiplex families ( Tables 1 and 2 ). There were no significant differences between probands from simplex and multiplex families with respect to any genotypic or phenotypic feature considered, including the presence of a large (>500 kb) rare CNV (Tables 1 and 2 ).
The recurrence rate of any CHD in first-to third-degree relatives of probands with TOF was significantly increased (0.94%; Table 4 ) relative to general population expectations (0.58%; RR, 1.6; 95% CI, 1.3-2.0). The recurrence risk for any CHD was highest for first-degree relatives (Table 4) , with risk to offspring of probands (4.8%) significantly greater than that to parents (0.8%; RR, 5.8; 95% CI, 2.6-12.9) or siblings (1.6%; RR, 3.0; 95% CI, 1.5-5.8). For severe CHD, the risk was markedly higher in these families (0.43%) than in the general population (0.061%; RR, 6.9; 95% CI, 5.2-9.2). The recurrence risk to offspring of severe CHD was 2.3%, significantly greater than the expected population prevalence of severe CHD in children (0.15%; RR, 15.6; 95% CI, 7.9-31.0).
Overall, a family history of CHD was significantly more likely in (male and female) paternal ancestors (55/4548 [1.2%]) than in maternal ancestors (31/5083 [0.6%]; RR, 2.0; 95% CI, 1.3-3.1). Among the 26 affected second-degree ancestors and 34 affected third-degree relatives, 18 (69.2%) and 23 (67.6%) were in the paternal line, respectively. Eight of 9 affected parents of probands were fathers, and thus the likelihood of CHD in a father (1.5%) was significantly greater than in a mother (0.2%; RR, 8.0; 95% CI, 1.0-63.7). In contrast, 11 (6.3%) of the 174 offspring of 94 female probands had CHD, a nonsignificantly greater prevalence in comparison with the 6 (3.4%) of 179 offspring of 96 male probands (RR, 1.9; 95% CI, 0.7-5.0). Abbreviated pedigrees for cases of direct vertical transmission (parent to proband and proband to offspring) are presented in the Figure. In these 22 cases (21 with available microarray data), 4 probands had a large rare CNV (Figure) . Only 2 of 9 parents presented with severe lesions, in comparison with 8 of 17 offspring (Figure) . Nine of the 11 affected offspring of female probands with TOF were female (Figure) .
Spectrum of CHD in Affected Relatives
Conotruncal lesions as a group, and TOF in particular, were the anomalies most commonly reported in first-and seconddegree relatives, with the prevalence decreasing with increasing genetic distance from the proband ( Table 5 ). As expected, the highest concordance figures for conotruncal lesions were in offspring (47.1%; 6 of 8 with TOF) and siblings (47.1%; 8 of 8 with TOF; Table 5 ). Many affected relatives had known nonconotruncal lesions, including intracardiac shunts and leftsided lesions ( Table 5 ). Of the 108 total affected relatives, 49 ‡Individual with a CNV >500 kb in size (large) and present in <0.1% of 2357 population-based controls (rare), 7 of the n=403 probands (n=73 from multiplex families) with genome-wide microarray data available. 22q11.2 deletions were a priori excluded. Comparisons of probands from simplex and multiplex families on the basis of other forms of rare CNV burden (eg, genic or nongenic CNVs, exonic or nonexonic CNVs, gain or loss CNVs, large or all size CNVs, and rare 7 CNVs) were similarly nonsignificant (data not shown). 
Discussion
To our knowledge, this is the first study of reproductive fitness in TOF and the first to report offspring recurrence risk figures for what would generally be considered idiopathic TOF. There are immediate implications for both the evolutionary biology of TOF and genetic counseling of affected individuals. Reproductive fitness and transmission patterns are relevant to discovering and interpreting molecular genetic risk factors for TOF, particularly as there were no discernable effects of (non-22q11.2 deletion) rare CNV burden on these genetic parameters. The results are also consistent with the existence of a broad, genetically related spectrum of CHD that includes TOF and anatomically discordant lesions.
Reproductive Fitness and Contemporary Selective Pressures
As hypothesized, adults with TOF had significantly reduced reproductive fitness (fewer total offspring and more childlessness) than a comparison group without CHD. This suggests that there remains a major negative selective pressure against TOF, despite the improvements in survival secondary to advances in cardiac surgical repair. This seems to be mediated, in part, by the extracardiac features that are associated with TOF. Analogously, we previously showed that reproductive fitness was reduced in adults with 22q11.2DS compared with controls, and that selected features (but not serious CHD) were significant predictors of fitness in this multisystem condition. 13 Nonetheless, contemporary reproductive fitness in TOF is likely to be much improved relative to previous decades. That no aspect of rare CNV burden was associated with a significant decrease in fitness suggests a potential role for inherited variants yet to be discovered in the genetic architecture of TOF.
In women with surgically corrected TOF, fertility is generally not impaired and pregnancy is well tolerated, 24,25 although some studies have reported a slightly increased rate of pregnancy †Includes dizygotic twins (n=9), none of whom had CHD; excludes monozygotic twins (n=4), 3 of whom had CHD (see text and Table 5 ).
‡Includes grandparents, aunts, uncles, half-siblings, nieces, nephews, and grandchildren.
§Includes nieces, nephews, and grandchildren only. loss. 26, 27 It is possible that a considerable proportion of adults with TOF may not have children because of personal choice, 24 including potential fears about recurrence or incorrect advice about relative contraindications provided by healthcare providers (for women). 28 Indeed, a large recent study of pregnancy in TOF reported that most women with TOF desired children, and the most common reason given for childlessness was youth (not ready). 27 Of note, coinciding with the beginning of the era of neonatal corrective surgery for TOF as a standard of care, 22 we found that female sex began to be associated with greater reproductive fitness than male sex in TOF. This was in contrast to the older individuals in our cohort, where reproductive fitness in men was similar to that of the age-matched comparison group. Consistent with this potential generational cohort effect is the observation that affected parents of probands with TOF were more likely to be men and less likely to have severe lesions (compared with affected offspring of probands).
Offspring Recurrence Risks and Transmission Patterns
The rate of recurrence of CHD in offspring of probands with TOF (4.8%) was modestly elevated compared with previous reports (1.2-4.2%), [29] [30] [31] [32] despite the exclusion of major risk factors like 22q11.2 deletions. This was driven, in part, by a notably higher recurrence rate in offspring of male probands (3.4%) than has been previously reported (1.4%-1.6%). 29, 30, 32 More recent studies of pregnancy in women with TOF have reported varying offspring risks for CHD from 2.2% to 6.1%. 24-27 A 9.8% recurrence risk reported in 1 of these studies 25 included a proband and her 2 offspring, all with 22q11.2DS; exclusion of these offspring would reduce their recurrence risk estimate for CHD to a more accurate 5.1%. Thus, the risk to offspring of women with TOF in the present study (6.3%) is comparable with the higher end of recent estimates. Of note, the relative recurrence risk for severe lesions in offspring of probands with TOF was 15.6, whereas a large Danish registry study estimated a relative recurrence risk of 11.7 for conotruncal defects in all first-degree relatives. 33 Neither large rare CNVs nor other kinds of rare CNVs were, in the aggregate, significant predictors of having an affected child or positive family history. This suggests that other (perhaps multiple) genetic factors may also play a major role in the inheritance of TOF-related CHD, consistent with the long-posited multifactorial model. 34 As in previous studies, 30, 32 we found a nonsignificantly increased risk for CHD in offspring of mothers, compared with fathers, with TOF. The sex skewing observed in the affected offspring of female probands with TOF is suggestive of possible male lethality. In contrast to these apparent maternal effects, we also report for the first time a significantly increased prevalence of CHD in patrilineal ancestors than in matrilineal ancestors, even when parents are excluded. The extent to which this observation is the consequence of a biological phenomenon, rather than the result of some sort of ascertainment bias, remains to be elucidated and is deserving of future study. Parental cohort effects predating the modern era of pediatric cardiac surgery, when pregnancy may have been poorly tolerated or considered to be contraindicated for women with CHD, could explain the increased proportion of fathers with CHD compared with mothers but not the differences among second-and third-degree relatives. There, one would have to posit decreased reproductive fitness in unaffected female carriers with a predisposition to CHD. One potential molecular mechanism that could be consistent with the results of a recent whole exome sequencing study in CHD is the possibility of imprinting effects. 11 Generational effects, sampling strategies, and inclusion/ exclusion criteria may explain other minor differences between our recurrence risk estimates and those of older family studies. 29, 30, 34, 35 In particular, ≤15% of TOF cases are now known to be associated with a 22q11.2 deletion, 14, 15 where there is a 50% risk of transmission of the deletion at each pregnancy and where individuals with 22q11.2 deletions have a 40% to 60% risk of serious CHD of varying anatomy. 14, 16 Furthermore, relatives of adults with CHD and 22q11.2DS are at increased risk for CHD even if they do not have a 22q11.2 deletion themselves. 16, 17 Exclusion of 22q11.2DS and other identifiable genetic syndromes in this study thus increases confidence in the empirical recurrence risk statistics intended for those with TOF of unknown origin. 18 Consistent with the results of the family study reporting these statistics, 18 third-degree relatives in our study showed a higher recurrence risk of CHD than seconddegree relatives. The majority of the second-degree relatives were aunts/uncles and grandparents, an older cohort on average than the third-degree relatives (predominantly first cousins). Generational effects in the form of improved survival with respect to severe CHD, and perhaps increased detection of mild CHD, are potential explanations for this observation.
Variable Expression of Cardiac Phenotypes in Familial TOF
Although the focus of previous family studies of TOF has been the recurrence of anatomically related (ie, conotruncal) lesions, discordant cardiac phenotypes have also been reported. 18, 29, 30, 35 We found a broad spectrum of CHD in relatives, including cases of left heart lesions. Consistent with previous reports of horizontal transmission, 18, 34 we found the highest concordance for TOF was among siblings, with decreasing rates of concordance with increasing genetic distance of the relative from the proband. The tendency for familial aggregation of partially concordant or discordant CHD in first-degree relatives of probands with a given subtype of CHD, including conotruncal lesions, was recently described in a Danish registry study. 36 Molecular genetic evidence relating to both syndromic and nonsyndromic TOF also supports a genetically related spectrum of CHD that includes anatomically discordant lesions. [37] [38] [39] [40] In particular, the overlap of genes and loci implicated by rare CNVs in studies of TOF and left-sided heart disease challenges traditional nosology. This may indicate a developmental/pathogenetic relationship between diverse cardiac defects that is comparable with the general pleiotropy observed in developmental disorders. 11, 41 
Study Advantages and Limitations
This study is the largest to date to examine family history in a cohort of adults with TOF and the first to quantify reproductive fitness. Individuals with 22q11.2 deletions and other recognizable genetic syndromes were excluded. All probands were systematically assessed for syndromal features, and the majority were molecularly characterized with high-resolution genomewide microarrays. Studying pedigrees of adults allowed us to report on CHD recurrence in offspring and nieces and nephews-relatives unavailable for probands ascertained as children and of major interest in genetic counseling scenarios. Finally, this is the first study to fully characterize the spectrum of CHD occurring in families of probands with TOF. Family history was the main ascertainment tool for CHD, and relatives were not directly examined. Previous studies assessing the reliability of family history for ascertainment have shown that this method tends to underestimate the true prevalence of disease, with greater sensitivity for detection of severe than milder phenotypes. [42] [43] [44] The reliability of family history would also decrease with increasing relational distance from the proband. Although we found a diversity of cardiac anomalies in relatives, unspecified CHD was common in second-and third-degree relatives. Not all relatives with reported CHD had echocardiogram or cardiac catheterization data available to confirm their cardiac disease. Survival disadvantages for older relatives in our sample would mean that cases of early and suspicious deaths that could not be included here may well have been because of CHD. The negative findings with respect to rare CNV burden in the aggregate do not preclude the possibility that, as with 22q11.2 deletions, specific variants are associated with specific effects on fitness and transmission patterns.
The prevalence and genetic architecture of TOF is not static. On the one hand, reproductive fitness among women born in the modern era of neonatal corrective surgery may continue to normalize. On the other hand, in utero detection of CHD (or of known genetic risk factors, such as 22q11.2 deletions) followed by termination of pregnancy is an important contemporary issue. Recent estimates are that ≤58% of pregnancies are terminated after identification of CHD, which may account for a significant reduction (≈21%) in the current birth prevalence. 45 Although it is impossible to know with absolute certainty all pregnancy outcomes in our sample, we recorded only 1 case of pregnancy termination (for D-transposition of the great arteries). The focus of our study was reproductive fitness and not pregnancy outcomes in women with TOF. Our study was neither designed nor powered to study maternal and neonatal risk factors such as maternal smoking, poor baseline cardiac function, and the use of cardiac medications. 27, 46 Clinical Implications Family history remains a useful tool for determining disease risk, even in the molecular age and when genotypic data are available. 47 Obtaining a detailed 48 family history in the clinical patient encounter, including enquiry about early and suspicious deaths and heart murmurs in relatives, will help clinicians to identify the significant minority of individuals with TOF who have a family history of CHD. Although reproductive fitness remains decreased overall in TOF, many affected adults will have offspring, and it is clear that the risk of CHD in offspring of both men and women with TOF is greatly increased. This emphasizes the importance of preconception counseling and of pre-and postnatal screening for CHD in offspring, for all affected individuals (men and women) and their partners. The potential benefits of such general genetic counseling are clear. 4 Individualized genetic counseling would be possible where clinical genetic testing is indicated and available, for example, for individuals with large rare CNVs such as 22q11.2 deletions and 1q21.1 duplications. 7, 49 Comparable individualized counseling may soon be extended to multiple other genetic factors that await clinical detection for individuals with TOF and other CHDs.
